$SOPH

SOPHiA GENETICS SA

$5.01
+0.13 (+2.66%) Today

About SOPHiA GENETICS SA

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. The company has a partnership with Synnovis to bring blood-based cancer testing to patients in the United Kingdom. The company was incorporated in 2011 and is based in Rolle, Switzerland.

CEO
Dr. Jurgi Camblong M.B.A., Ph.D.
Employees
415
Headquarters
Rolle, Switzerland
Sector
Healthcare
Industry
Health Information Services

Key stats

Market Cap
$359.67M
P/E Ratio
Avg Volume (3M)
104.26K
EPS
$-1.18
Day's Range
$4.89 – $5.13

Fundamentals as of Jun 16, 2026